1. Introduction
Version followed: live blood analysis (LBA) as its promoters describe it, namely the dark-field "nutritional microscopy" sold with supplements and the Enderlein/Béchamp-derived pleomorphic reading popularised by Robert O. Young's "New Biology" and pH Miracle programme, together with how US, UK and Australian regulators classify it. This guide describes the method as its promoters and regulators describe it and sets out the psychotherapist's own work alongside it; the psychotherapist does not perform, interpret, sell or recommend the test. Section 4 is the therapist's own work with a client who has had, or is considering, the test.
What it is. A practitioner pricks the client's fingertip, places a drop of fresh, unstained blood under a cover slip and views it through a dark-field microscope, usually projected onto a monitor so the client watches the cells, which appear as dark bodies outlined in light. Images or video may be given to the client. Names include live cell analysis, live blood testing, nutritional microscopy, dark-field blood microscopy, Hemaview, free radical blood screening and nutritional blood analysis. [source: Barrett, Quackwatch; ASA 2015; CMS Special Alert] Some promoters also offer a "dry blood" variant; Young is reported to have trained in "live and dry blood microscopy". [source: Gorski 2014] [uncertain: not verified]
Promoters' account of how it works (attributed). Practitioners claim the image shows vitamin and mineral deficiencies, toxicity, allergy tendencies, excess fat, liver weakness, immune activity, organ stress, digestive problems or food intolerances, and some claim early signs of cancer, diabetes or cardiovascular disease. Commonly reported "findings" include rouleaux (red cells stacked like coins) read as acidity, "crystals", "parasites", and yeasts or bacteria "budding" from red cells. [source: Barrett; Good Thinking Society; Ernst 2023] The pleomorphic theory behind the Enderlein-derived reading holds that a tiny life unit (Enderlein's "protit", Béchamp's "microzyma") and a permanent "endobiont" live in blood and tissue and change form (primitive, bacterial, fungal, viral) as the internal medium shifts in pH, and that dark-field microscopy of living blood reveals these forms. [source: A Distant Mirror (proponent page)] Young holds that overacidification is the cause of disease, describes the body as "alkaline by design and acidic by function", and claimed that red cells change into bacteria and back. [source: Gorski 2014] The publisher's description of The pH Miracle calls blood pH "the single most important health measurement" and ties it to diet. [source: Hachette, The pH Miracle] The "change" model therefore runs: image shows a disordered "terrain" → diet, alkalising regime and supplements → repeat microscopy shows improvement. Results are typically used to sell supplements (enzymes, algae, probiotics, multivitamins), restrictive diets, colonic irrigation and repeat consultations. [source: Barrett; Good Thinking Society; CMS Special Alert]
Who practises it. Naturopaths, nutritional therapists, chiropractors, some medical doctors and unqualified sellers; in the 1990s a multilevel company promoted it at chiropractic conventions, and a US federal review estimated 10,000 to 15,000 practitioners. [source: Barrett, citing HHS OIG 2001] Short trainings are marketed to "certified practitioners and students", for example a four-day online course with a microscope purchase, not eligible for continuing-education credit. [source: NANP partner-school listing] In the UK, practitioners need no qualification and no accredited UK laboratory offers the test. [source: Lab Tests Online UK]
Status in one line each.
- Evidence: blinded studies summarised in the literature found low inter-observer reliability (kappa about 0.35) for Enderlein-style analysis, poor detection of metastatic cancer (sensitivity 0.25), and "bacteria-like" forms that were membrane vesicles and protein aggregates from blood decaying on the slide. [source: Ernst 2023, summarising El-Safadi et al. and two other studies] [uncertain: primary papers not verified directly] Lab Tests Online UK states there is no evidence it can reliably diagnose disease and that serious conditions such as leukaemia are often missed.
- United States: CDC (1996) and CMS (1997) classified LBA as high-complexity testing; any facility doing it must hold CLIA certification and meet personnel, proficiency-testing and quality requirements; it is a non-covered Medicare service. [source: CMS Special Alert] State boards have disciplined chiropractors for it (Vermont 2003, Rhode Island 2005, Texas 2006). [source: Barrett]
- United Kingdom: the ASA/CAP position (2015) is that LBA may be advertised only on an availability basis (showing magnified cells), without claims about health, deficiencies, toxins, parasites or medical conditions; testimonials and before-and-after images are not evidence. [source: ASA 2015] The Cancer Act 1939 bars advertising cancer treatment; a practitioner trained by Young was convicted of nine offences in 2014. [source: Good Thinking Society; ASA 2015]
- Australia: unregistered practitioners are answerable to state health complaints commissioners, which can issue prohibition orders; a naturopath was banned for life in 2008 for offering LBA among other services. [source: Good Thinking Society; HCSCC South Australia] [uncertain: not verified]
- Robert O. Young: arrested in 2014 on 18 felony counts; convicted in 2016 on two counts of practising medicine without a licence; in 2017 pleaded guilty again and admitted he held no accredited post-high-school degree and was not a microbiologist, haematologist, medical doctor, naturopathic doctor or trained scientist. [source: Gorski 2014; Skeptics NZ 2016; Times of San Diego 2017] See also 117.
2. Framework
There is no manualised psychotherapy for LBA. The framework below is the therapist's own sequence of work when the test enters therapy. [synthesis]
What the client goes through (as sources describe it). A short session of finger-prick sampling, live viewing of the monitor with the practitioner narrating what the shapes "mean", printed or recorded images, then a recommendation of diet, supplements or other services and an invitation to return for repeat testing to "see the change". [source: Barrett; Good Thinking Society] Clients therefore often arrive in therapy with a vivid visual memory of "something wrong in my blood".
Therapist phases.
- Notice and ask (any session; often at intake or when health, diet or money comes up). Goal: know that the test happened, what was said, what was bought. Move on when the facts are recorded.
- Understand meaning (folded into ongoing work). Goal: the client's explanatory model, hopes, and what the images did to their sense of their body. Move on when the client feels understood and can name what they want from their health.
- Informed, values-based decision (as decisions arise). Goal: the client chooses what to do next, with accurate information about what the test can and cannot show and with conventional assessment available. Move on when the decision is the client's own and medical care is not being displaced.
- Coordinate (with consent, any time). Goal: the GP or pharmacist knows about supplements, diets and symptoms.
- Risk check and reporting (immediately when risk appears; it can pre-empt phases 2–3). Goal: no delayed diagnosis, no harm to a child, no eating-disorder escalation, no ongoing exploitation.
- Address what remains (as long as needed). Health anxiety, somatic symptom distress, grief, regret or anger, using established approaches (cross-reference Domain II).
Format: individual, within the ongoing therapy; family or couple sessions where a partner or parent is driving or opposing the testing. [synthesis]
3. Guiding principles
- Out of scope to perform or interpret. The therapist never reads the client's images, suggests what they show, or recommends, sells or refers for the test or its products. Practical meaning: decline to look at the images "diagnostically"; you may look at them with the client as an object of feeling. [source: APA Ethics Code 2.01 Boundaries of Competence]
- Ask routinely and without judgement. Disclosure keeps the client informed and in control and lets clinicians check safety and interactions. Practical meaning: ask about all tests, supplements and practices in the same neutral tone as about sleep or alcohol. [source: NCCIH tips]
- Attribute, do not adjudicate the theory. Describe pleomorphism and "acid terrain" as the client's practitioner holds them; give evidence and regulatory status plainly when relevant and asked. Practical meaning: "Your practitioner sees it as…; the regulators and lab bodies say…". [synthesis]
- Base statements on sources. Information you give about the test should come from regulators and laboratory bodies, not opinion. Practical meaning: keep Lab Tests Online UK, ASA or CMS wording at hand. [source: APA Ethics Code 2.04 Bases for Scientific and Professional Judgments]
- Autonomy with protection. Adults decide; your job is that they decide with accurate information and without pressure from either side. Practical meaning: no persuasion campaigns; name risks clearly once, then support. [synthesis; APA Ethics Code 3.10 Informed Consent]
- Conventional assessment stays open. Unvalidated tests can miss real disease; lab bodies advise discussing results with a qualified doctor and using standard tests. Practical meaning: whenever symptoms are present, the GP route is named. [source: Lab Tests Online UK]
- Cooperate with other professionals, with consent. Practical meaning: offer a letter or call to the GP or pharmacist; never contact the LBA practitioner to argue. [source: APA Ethics Code 3.09 Cooperation with Other Professionals; 4.05 Disclosures]
- No conflicts of interest. Practical meaning: do not hold, rent or train in an LBA microscope or sell supplements; disclose and refer on if you have links to this industry. [source: APA Ethics Code 3.06 Conflict of Interest, 3.08 Exploitative Relationships]
- Avoid harm, including shame. Practical meaning: a client who paid for the test is not foolish; ridicule ruptures the alliance and pushes the topic underground. [source: APA Ethics Code 3.04 Avoiding Harm; synthesis]
- Risk overrides neutrality. Delayed medical care, children, pregnancy, eating-disorder signs and financial exploitation call for active response. [synthesis]
4. Intervention inventory
All items are the psychotherapist's own work alongside the test. Example language is illustrative wording, not a script from any source. Unless a source is given, steps are [synthesis].
4.1 Routine, non-judgemental enquiry and recording
- Purpose / when: At intake, at reviews, and whenever health, diet, supplements, fatigue or money come up. Many clients do not volunteer complementary tests unless asked. [source: NCCIH tips]
- Steps: (1) Ask about all health tests and practices in one neutral list (GP tests, private tests, blood or hair or saliva tests, supplements, diets). (2) If LBA is named, record: when, where, by whom (practitioner type), what was said, what was bought or recommended, cost, planned repeat tests, and whether a doctor knows. (3) Record the client's own words for the findings, in quotation marks, not as clinical facts. (4) Note any symptom that has not been medically assessed. [synthesis; NCCIH tips on keeping a full list]
- Example language (illustrative): "Lots of people use tests and treatments outside the NHS or their insurer. Have you had any blood, hair or other tests privately, or been shown your blood under a microscope?"
- Watch for: A flinch or apology ("I know you'll think it's silly") signals expected judgement; slow down. Working: the client mentions new tests or products spontaneously in later sessions.
4.2 Eliciting the test narrative
- Purpose / when: After disclosure, to understand what the client saw and was told, because the live monitor experience is often vivid and persuasive.
- Steps: (1) Ask the client to walk you through the appointment in sequence: arriving, the finger prick, watching the screen, what the practitioner pointed to and said. (2) Ask what they felt at each point (curiosity, alarm, relief). (3) Ask what was recommended next and what it cost. (4) Ask what they believe now about their blood and body. (5) Reflect the sequence back without endorsing or correcting.
- Example language (illustrative): "Take me back to the moment the picture came up on the screen. What did they point at, and what went through your mind?"
- Watch for: Images that the client replays intrusively, words like "parasites" or "toxic" producing disgust or panic (see 4.12), and any statement that the practitioner advised against seeing a doctor or stopping medical treatment (see 4.8; UK regulators have acted on such advice). [source: ASA 2015; Good Thinking Society] Working: the client can tell the story with less arousal and separate "what I saw" from "what I was told it meant".
4.3 Exploring meaning, hopes and explanatory model
- Purpose / when: To learn what draws the client: a sense of control, a visible explanation for unexplained symptoms, hope, distrust of medicine after being dismissed, identity or community (wellness networks, alkaline-diet groups).
- Steps: (1) Ask what led them to the test and what they hoped it would show. (2) Elicit their explanatory model in their own terms (e.g. acidity, terrain, toxins). (3) Ask what conventional medicine has and has not offered them. (4) Ask what it would mean if the test were right, and if it were wrong. (5) Summarise the needs underneath (to be believed, to act, to feel safe). [synthesis]
- Example language (illustrative): "It sounds like, after months of being told your bloods were normal, seeing something on that screen finally felt like an answer. What did that answer give you?"
- Watch for: Experiences of medical dismissal (validate these; they are often real), all-or-nothing trust, identity fusion with a programme or leader. Working: the client names their underlying need and begins to consider other ways to meet it.
4.4 Responding to requests to interpret or endorse
- Purpose / when: When the client brings images or reports and asks "What do you think this shows?" or asks you to support the regime.
- Steps: (1) Thank them for sharing. (2) State your role plainly: you cannot read blood images and do not recommend tests or products. (3) Offer what you can do: look at the images together as something that has affected them, and help them get a qualified medical opinion. (4) Do not keep copies as clinical evidence; note in the record that images were shown. [source: APA Ethics Code 2.01; synthesis]
- Example language (illustrative): "I'm not trained to read blood under a microscope, so I can't tell you what this shows, and I wouldn't want to guess about your health. What I can do is help with how this has left you feeling, and help you get it looked at by a doctor if you'd like."
- Watch for: The client hearing your neutrality as rejection; check ("How was that to hear?"). Working: the client stops seeking your verdict and uses sessions for their own decisions.
4.5 Offering information about what the test can and cannot show (with permission)
- Purpose / when: When the client is deciding whether to continue testing or act on results and wants information.
- Steps: (1) Ask permission: "Would it help to know what regulators and lab organisations say?" (2) Share briefly from named sources: laboratory medicine bodies state there is no evidence it reliably diagnoses disease, that different practitioners reach different diagnoses from the same sample, and that serious conditions such as leukaemia are often missed [source: Lab Tests Online UK]; in the UK the advertising regulator does not allow claims that it detects deficiencies, toxins, parasites or disease [source: ASA 2015]; in the US it is classed as high-complexity lab testing that needs CLIA certification [source: CMS Special Alert]. (3) Ask what the client makes of this. (4) Leave space; do not repeat. (5) Offer to print or point to the source page.
- Example language (illustrative): "Here's what the UK advertising regulator and the laboratory medicine association say about this kind of test. You may already know some of it. What do you make of it?"
- Watch for: Defensiveness, or relief (some clients wanted permission to stop). Over-persuasion by you is the main risk; one clear offer is enough. Working: the client weighs the information in their own words.
4.6 Supporting an informed, values-based decision
- Purpose / when: When the client faces a choice: further tests, a restrictive diet, costly supplements, or a conventional medical assessment.
- Steps: (1) Clarify the decision in one sentence. (2) Elicit values (health, control, money, family, trust). (3) Help the client prepare the questions NCCIH suggests asking about any complementary approach: is it safe, does it work, could it interact with medicines? [source: NCCIH tips] (4) List options, including "conventional assessment first" and "both". (5) Ask what each option would cost them financially and emotionally. (6) Let the client decide; record that the decision was theirs. [synthesis]
- Example language (illustrative): "You've said being in charge of your health matters most to you. Which of these options leaves you most in charge, including if things change?"
- Watch for: Decisions made under time pressure or fear from the practitioner's warnings; pressure from family either way. Working: the client can state the reasons for their choice and a point at which they would review it.
4.7 Coordinating with the client's doctor or pharmacist (with consent)
- Purpose / when: When supplements, diets or symptoms are involved, or the client is on prescribed medicines. Some practices can interact with conventional medicine. [source: NCCIH tips]
- Steps: (1) Ask consent for contact and agree exactly what will be shared. (2) Encourage the client to bring a full written list of supplements, diets and tests to the GP or pharmacist. [source: NCCIH tips] (3) If the client wishes, write a brief factual note: test had, symptoms reported, distress level, request for review. (4) Never advise the client to start, stop or change a medicine or supplement; route those questions to the prescriber or pharmacist. (5) Record consent and contacts. [source: APA Ethics Code 3.09, 4.05; synthesis]
- Example language (illustrative): "Would you be OK with me letting your GP know you've been worried about your blood and are taking several supplements? I won't say anything you haven't agreed to."
- Watch for: Fear that the GP will mock them; help them plan how to raise it. Working: a medical review happens and the client reports it.
4.8 Risk check: delayed, reduced or abandoned medical care
- Purpose / when: Whenever the client has symptoms, a diagnosed condition (especially cancer or diabetes), or reports being told the test found or excluded disease. The most serious harm named by consumer and laboratory sources is a missed or delayed genuine diagnosis; one reported case involved a cancer patient advised to stop chemotherapy in favour of a supplement, and the UK regulator cited a practitioner who called choosing chemotherapy, surgery or radiotherapy a "dumb move". [source: Good Thinking Society; Lab Tests Online UK; ASA 2015]
- Steps: (1) Ask directly whether any medical appointment, test or treatment has been postponed, reduced or stopped since the LBA. (2) Ask about red-flag symptoms the client has not had assessed. (3) If care has been displaced, name your concern once, clearly and kindly, and ask permission to help them see their doctor. (4) Agree a concrete step (appointment booked, date) and follow up next session. (5) If the client has capacity and still declines, respect the decision, keep the door open, and document the discussion. (6) With cancer or other serious illness, support palliative or oncology team involvement where the client consents (cross-reference 172 for integrative oncology). [synthesis]
- Example language (illustrative): "I'm going to be direct because I care about how this goes for you. Has anything your doctor recommended been put on hold since the blood test?"
- Watch for: Statements that conventional treatment is "poison" or that the blood "proves" recovery; new or worsening symptoms explained away as "detox". Working: the client re-engages with medical care or makes a documented, informed choice.
4.9 Risk check: restrictive diets and eating-disorder awareness
- Purpose / when: LBA results are commonly followed by restrictive "alkaline" or exclusion diets and supplement regimes. [source: Good Thinking Society; Lab Tests Online UK ("unjustified exclusion diets")] Restriction justified by health fears can mask or feed an eating disorder or orthorexic pattern.
- Steps: (1) Ask what has changed in what and how the client eats since the test, without asking for amounts. (2) Screen for eating-disorder features with a validated screen your service uses: fear around "impure" food, rigid rules, guilt after eating, weight loss, social withdrawal around meals, compensatory behaviours. (3) If positive, refer for medical assessment and specialist eating-disorder input; restriction carries medical risks (including electrolyte disturbance) that need medical monitoring. (4) Do not advise on the diet itself. [synthesis] [uncertain: not verified; cross-reference the diet and detox guides in this domain and the eating-disorder guidance in Domain II]
- Example language (illustrative): "Since the test, has eating become more of a worry, or more about rules than enjoyment?"
- Watch for: Pride in restriction, dizziness or fainting, missed periods, children's diets being restricted by a parent. Working: the client can talk about food flexibly, or is under medical and specialist care.
4.10 Risk check: children, pregnancy and safeguarding
- Purpose / when: When a parent has had a child tested, is restricting a child's diet or giving products on the basis of the results, or is withholding medical care, vaccination or adequate nutrition; and when the client is pregnant.
- Steps: (1) Ask who else in the family has been tested and what has changed for them. (2) Distinguish a parent's choice of a harmless extra from deprivation of care or nutrition. (3) Where a child may be harmed (missed medical care, inadequate nutrition, harmful products), consult your safeguarding lead and follow local child-protection procedures. (4) For pregnancy, encourage the client to share all supplements, diets and tests with the midwife or obstetric team. (5) Discuss children's assent and parental consent in age-appropriate terms if a young person is your client. [synthesis]
- Example language (illustrative): "You mentioned your son had the test too. What changed for him afterwards, with food or seeing the doctor?"
- Watch for: A child's weight loss, missed medical appointments, a child frightened about "bugs in the blood". Working: the child's medical and nutritional needs are being met, or safeguarding is involved.
4.11 Risk check: financial exploitation, multi-level marketing and group pressure
- Purpose / when: Results are tied to sales: supplements, repeat tests, colonics, retreats; the test has been promoted through a multilevel company; and a high-cost residential programme run by one prominent promoter led to criminal charges. [source: Barrett; Good Thinking Society; Gorski 2014; Times of San Diego 2017]
- Steps: (1) Ask what the client has spent and is committed to spend. (2) Ask whether they are being recruited to sell products or train as a tester. (3) Explore group dynamics: is doubt punished, are outside sources discouraged, is a leader beyond question? (4) Help the client set their own limits (budget, review date). (5) Where deception or pressure is evident, discuss reporting options (4.14). [synthesis]
- Example language (illustrative): "If you add up the tests and products since March, what's the total? How does that sit with you?"
- Watch for: Debt, secrecy from partners, recruitment of friends, loss of other relationships. Working: spending matches the client's own limits; the client can voice doubts freely.
4.12 Health anxiety and somatic distress after "abnormal" images
- Purpose / when: Watching "parasites", "crystals" or "budding yeasts" in one's own blood can trigger or worsen health anxiety, disgust and body vigilance; repeat testing can become a reassurance-seeking or checking behaviour.
- Steps: (1) Assess health-anxiety features (preoccupation, checking, reassurance seeking, avoidance) and somatic symptom distress. (2) Formulate the cycle: image → threat interpretation → anxiety and bodily sensations → checking and repeat testing → short relief → more doubt. (3) Use established CBT for health anxiety: psychoeducation on attention and sensations, behavioural experiments, reducing checking and reassurance seeking, and work with intrusive images. (4) Coordinate with the GP so medical assessment is proportionate. (5) Cross-reference Domain II for full protocols. [synthesis; Domain II]
- Example language (illustrative): "Each time you book another test, how long does the relief last? Shall we look at what happens to the worry afterwards?"
- Watch for: Escalating testing across several unvalidated tests, sleep loss, disgust-driven rituals. Working: fewer tests and less checking, lower preoccupation ratings.
4.13 Grief, regret and anger after harm
- Purpose / when: After a delayed diagnosis, a death in the family linked to abandoned treatment, financial loss, or discovering that a trusted practitioner was unqualified (as Young admitted in court). [source: Times of San Diego 2017]
- Steps: (1) Make space for anger and shame without blame. (2) Separate responsibility: the client acted on information presented as expert. (3) Work with self-blame and counterfactual thinking. (4) Address family conflict where relatives disagreed about the test. (5) Support complicated grief with established bereavement approaches. (6) Offer help with complaints or reporting if the client wants it (4.14). [synthesis]
- Example language (illustrative): "You trusted someone who presented himself as an expert. Being angry about that makes sense."
- Watch for: Suicidal thoughts in severe regret or grief; assess using standard risk practice. Working: the client can hold the decision with less self-blame.
4.14 Reporting routes
- Purpose / when: When the client wants to complain, or when you have concerns about a practitioner, product claims or a child's safety. Discuss with the client and obtain consent except where safeguarding requires otherwise.
- Routes:
- United States: the State or Regional Survey Agency for CLIA laboratory compliance (CMS directs questions there and to LabExcellence@cms.hhs.gov) [source: CMS Special Alert]; the relevant state licensing board (chiropractic, medical, naturopathic) [source: Barrett]; the state attorney general or Federal Trade Commission for deceptive advertising [uncertain: FTC role not verified for LBA].
- United Kingdom: the Advertising Standards Authority for misleading advertising [source: ASA 2015]; Trading Standards for advertising cancer treatment under the Cancer Act 1939 [uncertain: enforcing body not verified]; the practitioner's professional body where one exists.
- Australia: the state or territory health complaints commissioner, which can issue prohibition orders against unregistered practitioners. [source: HCSCC South Australia]
- All jurisdictions: local child-safeguarding procedures where a child is at risk; your own professional body for advice.
- Example language (illustrative): "If you'd like to make a complaint, there are a few routes. We can look at them together, and you decide whether to go ahead."
- Watch for: Your own urge to report on the client's behalf without consent outside safeguarding. Working: the client chooses and follows a route, or makes an informed choice not to.
5. Handling problems
The sources describe the test, its regulation and its harms; they do not address psychotherapy. All responses below are [synthesis] unless a source is given.
- The client is certain the images prove illness. Do not argue about the image. Work at the level of decision and consequence: "Whatever the picture means, what would you want a doctor to check so nothing is missed?" Keep the GP route open (4.8). If certainty drives severe distress or rituals, move to health-anxiety work (4.12).
- The client hears any information as an attack on their practitioner or community. Repair first: acknowledge that you introduced something unwelcome, return to their goals, and only offer information again if invited (4.5). Ridicule or repeated correction tends to push the topic underground.
- Rupture after you declined to interpret images or endorse the regime. Name the moment, explain your role and limits again, and affirm that you take their symptoms seriously. Offer what you can do (4.4).
- Non-disclosure or partial disclosure. Often stems from prior judgement by clinicians. Re-ask in later sessions in a neutral list (4.1); do not interrogate.
- Overwhelm after alarming "findings". Use grounding and stabilisation before any information or decisions; postpone decision work until arousal is manageable; check sleep and safety.
- The client stops or refuses medical treatment for a serious condition. Name the risk once, clearly; offer a joint plan to talk to the treating doctor; respect capacity; document; keep the relationship open so they can return to care. Involve oncology or palliative teams with consent (4.8; see 172). If capacity is in doubt, consult and follow local procedures.
- A child is at risk. Safeguarding duties override confidentiality as your jurisdiction specifies; consult your safeguarding lead and follow local procedures (4.10).
- Family conflict. One partner or parent pays for testing, another opposes it. Use a joint session to surface each person's fears and values; avoid being recruited as the expert on either side.
- Financial or group pressure. Help the client set limits and identify trusted others outside the group; watch for isolation and recruitment into selling (4.11).
- The client asks you to train in or offer the test, or a colleague sells it. Decline; doing so would be outside competence and a conflict of interest. [source: APA Ethics Code 2.01, 3.06] If a colleague makes health claims for it, consider the professional-body and advertising routes in 4.14.
- Your own reactions. Contempt, rescue fantasies or anxiety about liability can distort the work. Use supervision; keep notes factual.
- Uncertainty about the law in your area. Regulation differs by country and state (CLIA in the US, ASA and the Cancer Act in the UK, complaints commissioners in Australia). Check current local guidance before advising on reporting. [source: CMS Special Alert; ASA 2015; HCSCC South Australia]
Sources
- Live Blood Cell Analysis: Another Gimmick to Sell You Something (Stephen Barrett, Quackwatch, rev. 2019)
- Alive to a serious advertising issue: live blood analysis (Advertising Standards Authority, 2015)
- CLIA Special Alert: Live Blood Cell Analysis (CMS)
- Unvalidated or misleading laboratory tests (Lab Tests Online UK, Association for Laboratory Medicine)
- Good Thinking About: Live Blood Analysis (Good Thinking Society)
- Live blood analysis, an ideal tool for quacks (Edzard Ernst, 2023)
- On the Work of Enderlein, Bechamp, and other researchers into pleomorphism (A Distant Mirror, proponent page, undated)
- Train in Live & Dry Cell Microscopy (Edison Institute of Nutrition, NANP partner-school listing)
- pH Miracle Living "Dr." Robert O. Young finally arrested (David Gorski, Science-Based Medicine, 2014)
- pH Miracle author admits he's no MD, microbiologist or trained scientist (Ken Stone, Times of San Diego, 2017)
- Split verdict for 'pH Miracle' author (Skeptics NZ, 2016)
- The pH Miracle (Hachette Book Group listing)
- Prohibition order public statement (Health and Community Services Complaints Commissioner, South Australia, 2021)
- Tips: Start talking with your health care providers about complementary health approaches (NCCIH)
- Ethical Principles of Psychologists and Code of Conduct (American Psychological Association)
- Book: Young, R. O., & Young, S. R. (2013 audiobook edition, Hachette Audio). The pH Miracle: Balance Your Diet, Reclaim Your Health.
- Studies cited only via Ernst 2023: El-Safadi S. et al. (dark-field microscopy and cancer detection); an Enderlein dark-field reliability pilot study; an ex vivo study of "bacteria-like" structures in incubated blood. [uncertain: not verified directly]